FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Westminster Pharmaceuticals Metoprolol Tartrate Tablets Recall

Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renat…

Westminster Pharmaceuticals LLC · Nashville, TN

Risk level
Class II
Reported by FDA
Aug 20, 2025
Recall ID
D-0582-2025
Check your lot numberHow we source this data

Summary

Westminster Pharmaceuticals recalled Metoprolol Tartrate Tablets starting Aug 6, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0582-2025 on Aug 20, 2025. Reason: CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level. Status: Ongoing.

Why it was recalled

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

Product description

Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10

Lot numbers, UPCs & expiration codes

Batch # R56240011, Exp Date: 2/28/26; Batch # R56240021, R56240031, Exp Date: 3/31/26; Batch # R56240041, R56240051, R56240061, Exp Date: 4/30/26; Batch # R56240071, Exp Date: 7/31/26

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0582-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 6, 2025
FDA report date
Aug 20, 2025
Quantity
4,456 1000-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Westminster Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-0582-2025, exactly as published.

Show all FDA fields
City
Nashville
State
TN
Status
Ongoing
Country
United States
Event ID
97395
Address
1321 Murfreesboro Pike Ste 607
Code information
Batch # R56240011, Exp Date: 2/28/26; Batch # R56240021, R56240031, Exp Date: 3/31/26; Batch # R56240041, R56240051, R56240061, Exp Date: 4/30/26; Batch # R56240071, Exp Date: 7/31/26
Postal code
37217-2693
Report date
Aug 20, 2025
Product type
Drugs
Recall number
D-0582-2025
Classification
Class II
Recalling firm
Westminster Pharmaceuticals LLC
Product quantity
4,456 1000-count bottles
Reason for recall
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10
Distribution pattern
Nationwide in the USA.
Recall initiation date
Aug 6, 2025
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Aug 12, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0582-2025, published Aug 20, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls